NC | S | PC | C | RC | |
n = 50 | n = 10 | n = 29 | n = 49 | n = 70 | |
ECOG PS* (0-4; 4worst) | 0.7 ± 1.0^ | 0.6 ± 0.5 | 1.1 ± 0.3 | 1.2 ± 0.7 | 2.5 ± 0.8 |
McGill QoL Total Score (0-10; 0 Worst)** | 7.0 ± 1.2 | 7.2 ± 1.0 | 5.2 ± 1.3 | 5.3 ± 1.5 | 4.9 ± 1.5 |
# Hospital days/follow-up days(%)*** | 4.6 ± 11.2 | 6.1 ± 13.9 | 13.5 ± 25.5 | 4.9 ± 11.6 | 30.8 ± 35.8 |
Chemotherapy Dose Reduction† | 4/17 (23.5%) | 1/1 (100%) | 3/9 (33.3%) | 7/16 (43.8%) | 8/16 (50%) |
Total fat mass by DXA (kg) †† | 26.1 ± 11.7 | 19.8 ± 10.9 | 19.9 ± 10.7 | 17.1 ± 9.4 | 13.0 ± 7.6 |
Total lean mass by DXA (kg) ‡ | 10.9 ± 2.1 | 7.3 ± 2.3 | 10.3 ± 2.8 | 8.3 ± 1.7 | 9.6 ± 2.2 |
Survival (wks) ‡‡ | 69.4 | 62.8 | 35.0 | 39.4 | 11.1 |
Median (95% CI) | (48.1–90.8) | (42.5–83.2) | (13.9–56.1) | (28.4–50.4) | (5.9–16.3) |